申请人:Takeda Pharmaceutical Company Limited
公开号:EP1849465A1
公开(公告)日:2007-10-31
The present invention provides a GPR receptor function regulator comprising the compound represented by the formula:
[wherein ring A is an optionally substituted isocyclic or heterocyclic ring, P is a bond or spacer, ring D is an optionally substituted monocyclic aromatic ring which may be condensed with a 5-to 7-membered ring, V is a bond or the group represented by the formula -CR14=CR15 - or - N=CR16- (wherein R14, R15 and R16 each represents a hydrogen atom or optionally substituted hydrocarbon group), Q is a bond or spacer, and W is a carboxyl or a group biologically equivalent to a carboxyl] or its salt or a prodrug thereof
本发明提供了一种 GPR 受体功能调节剂,包括由式表示的化合物:
[其中环A是任选取代的异环或杂环,P是键或间隔物,环D是任选取代的单环芳香环,可与5-7元环缩合,V是键或由式-CR14=CR15-或-N=CR16-代表的基团(其中R14、R15 和 R16 各代表一个氢原子或任选取代的烃基),Q 是键或间隔物,W 是羧基或生物等价于羧基的基团]或其盐或其原药